BizInsight Hub - global economic insights

Workers at Kyowa Industrial Co. in Takasaki, Japan, April 2025. Asian factories face mounting pressure as weak China and U.S. demand drag down manufacturing activity.(Representing AI image) Asian Factories Under Strain: How Soft China and Weak U.S. Demand Are Testing the Export Engine of the Global Economy  - Dr.Sanjaykumar pawar Table of Contents Introduction: The Fragile Engine of Global Growth Why Asia? Anatomy of an Export-Driven Success Story Recent Data & the Warning Signals  3.1 Manufacturing PMI Trends Across Asia  3.2 China’s Sixth Month of Factory Contraction  3.3 Country Snapshots: Japan, Taiwan, South Korea, Thailand Transmission Channels: How Weak Demand Spreads Stress  4.1 Demand Side: U.S. and China Slowdowns  4.2 Policy & Trade Shocks: Tariffs, Subsidies, and Uncertainty  4.3 Supply Chains & Input Costs Deeper Analysis: Structural Pressures and Vulnerabilities  5.1 Overreliance on Exports and Limited Domestic Demand  5.2 Technological Shi...

President Trump and Pfizer CEO Albert Bourla announce a landmark agreement in the Oval Office to lower Medicaid drug prices and launch the TrumpRx direct-to-consumer platform.(Representing ai image) Trump Strikes Landmark Deal with Pfizer to Lower Drug Prices: Inside the TrumpRx Revolution  - Dr.Sanjaykumar pawar Table of Contents Introduction: Why Drug Prices Define U.S. Healthcare Politics The Trump–Pfizer Agreement: What Was Announced Understanding U.S. vs. Global Drug Prices Medicaid’s Role in Drug Pricing Reform TrumpRx Website: A New Direct-to-Consumer Model The Economic and Political Context of the Deal Pfizer’s Business Strategy: Balancing Profits and Public Pressure The Role of Pharmacy Benefit Managers (PBMs) in the Pricing Puzzle Tariffs on Imported Drugs: A Complicating Factor How Patients May (and May Not) Benefit Industry and Political Reactions Global Implications of Price Benchmarking Risks, Challenges, and Potential Loopholes Expert Insights and Pu...